During the past decade, University of Rochester Medical Center conducted 344 clinical trials. In the 10-year time frame, 344 clinical trials started and 170 clinical trials were completed, i.e. on average, 49.4% percent of trials that started reached the finish line to date. In the past 5 years, 152 clinical trials started and 95 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Rochester Medical Center" #1 sponsor was "University of Rochester" with 152 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 113 trials sponsored, "Pfizer" with 23 trials sponsored, "Abbott Medical Devices" with 15 trials sponsored and "SWOG Cancer Research Network" with 15 trials sponsored. Other sponsors include 440 different institutions and companies that sponsored additional 286 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rochester Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "National Institute on Aging (NIA)" with 27 trials as a collaborator, "University of Rochester" with 27 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 15 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 15 trials as a collaborator. Other collaborators include 559 different institutions and companies that were collaborators in the rest 346 trials.

According to Clinical.Site data, the most researched conditions in "University of Rochester Medical Center" are "HIV Infections" (118 trials), "Heart Failure" (14 trials), "Multiple Myeloma" (11 trials), "Alzheimer's Disease" (9 trials) and "Influenza" (9 trials). Many other conditions were trialed in "University of Rochester Medical Center" in a lesser frequency.

Most popular intervention types in "University of Rochester Medical Center" are "Drug" (442 trials), "Device" (83 trials), "Biological" (82 trials), "Behavioral" (71 trials) and "Other" (70 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (104 trials), "Zidovudine" (37 trials), "Didanosine" (20 trials), "Stavudine" (14 trials) and "Indinavir sulfate" (13 trials). Other intervention names were less common.

The vast majority of trials in "University of Rochester Medical Center" are 707 trials for "All" genders, 37 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 173 active trials in "University of Rochester Medical Center". 3 are not yet recruiting, 100 are recruiting, 64 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 468 completed trials in University of Rochester Medical Center, 3 suspended trials, and 86 terminated clinical trials to date.

Out of the total trials that were conducted in University of Rochester Medical Center, 81 "Phase 1" clinical trials were conducted, 222 "Phase 2" clinical trials and 197 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 151 trials that are defined as “Not Applicable".